SiRNA targeting lncRNA HOTAIR has been shown to suppress the progression of endometrial carcinoma in vivo demonstrating that targeting lncRNA HOTAIR can be a novel therapeutic strategy for endometrial cancer [151]. Here, HOTAIR is linked to endometrial carcinoma.